Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01857427Active Not Recruiting

A Prospective Observational Cohort to Study the Genetics of Obstructive Sleep Apnea and Associated Co-Morbidities

Role: lead

NCT01136122Not ApplicableWithdrawn

Effects of PAP Treatment of OSA in Patients With Heart Failure

Role: lead

NCT01005940Not ApplicableCompleted

Dental Device for Treatment of Sleep Apnea

Role: lead

NCT01853891Not ApplicableWithdrawn

Dim Light at Night in Patients With Obstructive Sleep Apnea

Role: lead

All 4 trials loaded